| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |